The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The impact of gender on the outcome of malignant melanoma: Overview of seven EORTC phase III trials.
A. Joosse
No relevant relationships to disclose
S. Collette
No relevant relationships to disclose
S. Suciu
No relevant relationships to disclose
E. de Vries
No relevant relationships to disclose
T. Nijsten
No relevant relationships to disclose
P. Patel
No relevant relationships to disclose
U. R. Kleeberg
No relevant relationships to disclose
U. Keilholz
No relevant relationships to disclose
A. M. Eggermont
No relevant relationships to disclose
J. W. Coebergh
No relevant relationships to disclose